Founded in 1880, with seed money from Thomas Edison, Science continues to be at the center of the very best in research across the sciences, with articles that consistently rank among the most cited in the world. Science articles are peer-reviewed, and written to appeal to both scientist and layman. Regular issue features include a news and comment section, book reviews, and coverage of scientific meetings and seminars. The News section features late-breaking news and in-depth news analysis. Compass, an opinion section, publishes letters and commentary by scientists on current science issues. The TechSight section focuses on leading edge techniques and technologies. Topics include: bioinformatics, genome sequencing, and protein sequencing. This section is published in the third issue every month. The Research section features original investigative research and reporting. Other departments include NetWatch, This Week in Science, ScienceScope, Random Samples and New Products.

Medscape was created for medical specialists, primary care physicians, and health professionals and offers medical news, clinical trial information, review articles, journal commentary, expert columns, patient education articles and book reviews. It also includes Web-based services for verifying insurance information, Medline and other search engines, as well as a physician directory enabling users to find physicians by practice, location or specialty.

The BMJ is a leading international peer‑reviewed general medical journal that publishes high‑quality research, clinical reviews, expert analysis, news, opinion, education, evidence‑based guidance and commentary on clinical practice, public health, healthcare policy and related scientific and social issues affecting medicine and health professionals worldwide. It combines rigorous academic research with accessible content aimed at informing and improving healthcare decisions and outcomes globally.

Endpoints News covers Biopharmaceutical industry. Offers data-driven news and analysis for industry professionals covering research and development. Content is a combination of originally produced and curated from around the web and is available in real-time and via a daily newsletter. This site is available via RSS (Really Simple Syndication).

Impact Factor:22.66 (Source: Scimago Journal & Country Rank)Circulation: The figure is not currently disclosed.Aims of the journal:Nature Reviews Drug Discovery is a monthly journal aimed at everyone working in the drug discovery and development arena. In addition it seeks to provide the highest-quality reviews and perspectives covering the entire field, each issue includes news stories that investigate the hottest topics in drug discovery, timely summaries of key primary research papers and concise updates on the latest advances in fast-moving areas such as new drug approvals, patent law and emerging industry trends.Content: The journal covers the following subjects: Target discovery Rational drug design Combinatorial and parallel synthesis Medicinal chemistry Key compound classes Natural products High-throughput screening Novel therapeutic approaches to disease states Microarrays Bioinformatics and chemoinformatics Absorption, distribution, metabolism and elimination (ADME) Pharmacokinetics and pharmacodynamics Pharmacology Toxicology Pharmacogenomics and toxicogenomics Drug delivery Biopharmaceuticals Biotechnology Vaccines Clinical trial evaluation Regulatory issues PharmacoeconomicsEditorial contacts: See the list of editors here.The editorial office can be reached at naturereviews@nature.com.Manuscript submission:To be published in nature Reviews Drug Discovery a manuscript should meet the following criteria: Timely, accurate and balanced Important to scientists in the specific field Interesting and accessible to researchers in other areas of Drug DiscoverySubmit online at http://mts-nrdd.nature.com/cgi-bin/main.plex